Lv4
620 积分 2022-11-25 加入
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction
1个月前
已完结
LNCaP Model of Human Prostatic Carcinoma
1个月前
已关闭
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
2个月前
已完结
[RNA-binding protein ELAVL1 regulates SOX4 stability and promotes hormone-sensitive prostate cancer proliferation through m6A-dependent regulation]
2个月前
已关闭
Bimodal Fluorescent Conjugate Based on Prostate-Specific Membrane Antigen Ligands with the Chelating Agent DOTA and SulfoCy5 Dye: Synthesis, Radiolabeling, and Biological Activity
2个月前
已完结
A comparison of prostate cancer cell transcriptomes in 2D monoculture vs 3D xenografts identify consistent gene expression alterations associated with tumor microenvironments
2个月前
已完结
Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer
2个月前
已完结
Discovery of a Highly Potent PROTAC Degrader of p300/CBP Proteins for the Treatment of Enzalutamide-Resistant Prostate Cancer
2个月前
已完结
IGFBP3–SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer
2个月前
已完结
PM534, a Novel Colchicine Site Tubulin Inhibitor with Broad-Spectrum and Resistance-Overcoming Antitumor Activity
2个月前
已完结
皖公网安备34019202002308
